Analyser av Stille

Stille (Q1 initial take): Starting the year with a slam dunk despite FX-headwind - Redeye

Q1 delivered a broad beat versus our estimates with 19% organic growth and EBITDA 25% above our forecast, despite FX headwinds of ~SEK10m, w...

Redeye • 24 apr 08:58

Stille (Q1 preview): Navigating headwind, expecting a solid report - Redeye

Redeye expects a sequential decline against the exceptionally strong Q4, but continued double-digit YoY growth and an EBITDA margin of aroun...

Redeye • 22 apr 11:41

Stille: (Q4 review): Easing headwinds and solid outlook at 11x current year EV/EBITDA - Redeye

Stille’s soft share price development over the past months to us appears more sentiment-driven than fundamental following the Q4 report.

Redeye • 13 feb 09:46

Stille (Q4 initial take): Beat across the board despite FX headwinds - Redeye

Redeye's immediate impression of Stille's year-end report 2025 is positive.

Redeye • 12 feb 11:08

Stille (Q3 update): Prolonged headwind but valuation remains undemanding - Redeye

Redeye provides an updated view of Stille following the Q3 2025 report.

Redeye • 27 okt 2025 10:10

Stille (Q3 initial take): Continued headwinds but improving outlook - Redeye

Redeye provides its initial comments on Stille following the Q3 2025 report, which came in below our projections.

Redeye • 23 okt 2025 11:02

Stille Q2 2025: Initial comments – softer than anticipated - Redeye

Redeye sees a soft Q2 report from Stille, marked by headwinds in the surgical instruments business, including supply chain issues and the ph...

Redeye • 17 jul 2025 08:55

Stille: SEK100m UK acquisition at 1.2x sales - Redeye

Redeye’s initial view of the newly announced acquisition is positive.

Redeye • 03 jul 2025 14:52

Stille Q1 2025: Softer than anticipated but just a temporary bump on the road - Redeye

Redeye updates its outlook on Stille following a report that missed expectations due to temporary supply constraints, portfolio rationalisat...

Redeye • 25 apr 2025 11:17

Stille Q1 2025: Softer than anticipated across the board - Redeye

Redeye sees a softer-than-anticipated Q1 report from Stille, with sales and EBIT falling below our forecasts.

Redeye • 24 apr 2025 13:00

Stille Q4 2024: Bags another strong quarter - Redeye

Redeye makes positive revisions to its financial projections and fair value range following Stille's year-end report.

Redeye • 14 feb 2025 10:49

Stille Q4 2024: Initial take – Strong across the board despite impairment - Redeye

Redeye’s initial take on Stille’s year-end report is positive.

Redeye • 13 feb 2025 10:45

Stille: CEO resigns in mid 2025 - Redeye

Redeye leaves a short comment on Stille following the company's announcement that the CEO will resign in the June 2025.

Redeye • 13 dec 2024 14:28

Stille Q3 2024: Sustainable growth and expanding margins at a discount - Redeye

Redeye makes negligible changes to its forecasts and valuation following Stille's Q3 report.

Redeye • 25 okt 2024 11:01

Stille Q3 2024: Initial take – Solid, but slightly softer than our estimates - Redeye

Redeye see a Q3 report from Stille confirming continued organic growth and expanding margins, albeit slightly softer than we had estimated.

Redeye • 24 okt 2024 11:58

Stille Q2 2024: Solid across the board - Redeye

Redeye returns with an updated take following a solid Q2 report from Stille, showing very minor deviations compared to our estimates.

Redeye • 23 jul 2024 08:25

Stille Q2 2024: In line with estimates - Redeye

Redeye see a Q2 report from Stille aligning with our estimates in terms of both sales and profitability.

Redeye • 18 jul 2024 09:09

Stille Q1 2024: Another stable quarter - Redeye

Redeye upgrades its base case and forecasts following a solid Q1 report from Stille.

Redeye • 26 apr 2024 10:12

Stille Q1 2024: Continued momentum - Redeye

Redeye provides its comments on Stille following a solid Q1 report, which exceeded our sales estimates.

Redeye • 25 apr 2024 09:19

Stille Q4 2023: Above expectations and strong outlook - Redeye

Redeye slightly raises estimates and fair value range following a strong Q4 from Stille where sales and EBIT exceeded our estimates.

Redeye • 20 feb 2024 08:37

Stille Q4 2023: Another strong quarter - Redeye

Redeye regard Stille's Q4 report as strong as it came in slightly above our estimates in terms of both sales and EBIT.

Redeye • 16 feb 2024 09:08

Stille: Another leap forward - Redeye

Redeye adjusts its estimates and valuation following the SEK425m directed share issue and the acquisition of Fehling Instruments, which we b...

Redeye • 19 dec 2023 08:36

Stille: SEK425m directed share issue and acquisition - Redeye

Redeye observes strong press releases from Stille announcing a SEK425m directed share issue to finance the acquisition of Fehling Instrument...

Redeye • 29 nov 2023 09:07

Stille Q3 2023: Beat on sales and EBIT – positive outlook and attractive valuation - Redeye

Redeye recognizes a solid Q3 report from Stille, which unveiled nuggets such as 18% y/y sales growth and EBIT margin of 16%, both slightly s...

Redeye • 27 okt 2023 08:55

Stille Q3 2023: Initial take on the report – positive - Redeye

Redeye see's an uplifting Q3 2023 report from Stille, which came in above our estimates both in terms of sales and EBIT, we note a particula...

Redeye • 26 okt 2023 10:12

Stille Q2 2023: Solid progress - Redeye

Redeye returns with an update on Stille following its Q2 2023 report.

Redeye • 18 jul 2023 08:20

Stille Q2 2023: Initial comment - Redeye

Redeye sees a Q2 2023 report from Stille that exceeds our estimates in terms of both sales and EBIT.

Redeye • 14 jul 2023 08:55

Stille Q1 2023: A solid start to the year - Redeye

Redeye returns with an update on Stille following its Q1 2023 report.

Redeye • 28 apr 2023 09:48

Stille Q1 2023: Initial comment - Redeye

Redeye considers Stille's Q1 2023 report relatively strong as it adjusted for the one-off item came in above our estimate both in terms of s...

Redeye • 27 apr 2023 10:20

Stille Q4 2022: A Relatively Soft Ending to 2022 - Redeye

Redeye leaves its comments on Stille’s Q4 2022 report.

Redeye • 17 feb 2023 09:12

Stille: A Resilient Investment Case - Redeye

Redeye returns with an updated view of Stille following the Q3 2022 report.

Redeye • 01 nov 2022 08:23

Stille Q3 2022: First Impressions - Redeye

Redeye leaves its initial take on Stille's report for the third quarter of 2022, containing both positive and negative elements.

Redeye • 27 okt 2022 10:04

Stille Q2: Yet Another Strong Quarter – Operating Tables Continues to Grow Nicely - Redeye

Redeye sees yet another strong quarterly report from Stille where the operating tables segment once again surprised us positively.

Redeye • 15 jul 2022 10:55

Stille Q1’22: Strong Quarter, Despite Supply Chain Challenges - Redeye

Redeye sees a strong Q1’22 report from Stille, where sales in the operating tables segment surprised us positively.

Redeye • 29 apr 2022 10:25

Still(e) an Attractive Long-Term Case - Redeye

Redeye retains its positive long-term view of Stille following its year-end report, which came in largely in line with our expectations on a...

Redeye • 21 feb 2022 10:26

Stille Q4’21: Initial Take - Redeye

Redeye shares its initial take on Stille’s Q4’21 report, which came in slightly below our expectations on all levels except EBIT, which was ...

Redeye • 17 feb 2022 09:36

Stille: Q2, Solid Growth & Acquisition - Redeye

Redeye remains optimistic about the prospects of Stille following its Q2 report.

Redeye • 16 jul 2021 17:33